GORE FLOW REVERSAL SYSTEM
Report
- Report Number
- 2017233-2010-00151
- Event Type
- Injury
- Date Received
- April 8, 2010
- Date of Event
- March 12, 2010
- Report Date
- April 8, 2010
- Manufacturer
- W.L. GORE & ASSOCIATES
- Product Code
- NTE
- PMA / PMN Number
- K083300
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CA, US
- Reporter Occupation
- PHYSICIAN
Narratives
A REVIEW OF THE MFG RECORDS WAS CONDUCTED. RESULT - A REVIEW OF THE MFG RECORDS VERIFIED THE LOT MET ALL PRE-RELEASE SPECS. THE DEVICE WAS DISCARDED BY THE FACILITY AND THEREFORE AN ENGINEERING EVALUATION WAS UNABLE TO BE PERFORMED.
ON (B) (6) 2010, A (B) (6) MALE PT UNDERWENT CAROTID ARTERY STENTING AND ANGIOPLASTY FOR A LEFT INTERNAL CAROTID ARTERY (ICA) STENOSIS. A GORE FLOW REVERSAL SYSTEM WAS USED FOR EMBOLIC PROTECTION. THE GORE BALLOON WIRE (GBW) BALLOON AND THE GORE BALLOON SHEATH (GBS) BALLOON WERE INFLATED AND FLOW REVERSAL WAS CONFIRMED, ALTHOUGH IT WAS NOTED TO BE SLOW. WHILE CONFIRMING FLOW REVERSAL, THE GBW BALLOON APPEARED TO BE LOSING VOLUME. THE PHYSICIAN RE-TIGHTENED THE REMOVABLE HUB AND RE-INFLATED THE BALLOON TWICE BEFORE THE BALLOON REMAINED INFLATED. THE LESION WAS PRE-DILATED UNDER ACTIVE ASPIRATION. AT THE STENT WAS POSITIONED ACROSS THE LESION, THE PHYSICIAN NOTED STAGNANT FLOW REVERSAL. AIR WAS ENTRAINED IN THE GBS HUB AND BOTH HEMOSTASIS VALVES WERE OPENED TO RELEASE THE AIR; HOWEVER, THERE WAS NO BACK BLEEDING THROUGH THE VALVES. THE UNDEPLOYED STENT MAY HAVE OCCLUDED THE ICA. THE PT STARTED YAWNING. THE PHYSICIAN QUICKLY COMPLETED THE PROCEDURE. AT CASE COMPLETION, THE PT COULD NOT MOVE HIS RIGHT HAND OR FOOT. FIFTEEN - THIRY MINUTES LATER, THE PT RESUMED ALL NEUROLOGICAL AND MOTOR FUNCTION PRIOR TO ENTERING THE RECOVERY ROOM.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | GORE FLOW REVERSAL SYSTEM | NTE / TEMPORARY CAROTID CATHETER FOR EMBOLIC CAPTURE | NTE | W.L. GORE & ASSOCIATES | WLG380 | 7383053 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 79 YR | Other |